AKAP5
Basic information
Region (hg38): 14:64465499-64474503
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AKAP5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 24 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 0 | 3 |
Variants in AKAP5
This is a list of pathogenic ClinVar variants found in the AKAP5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-64468422-G-A | not specified | Uncertain significance (Mar 29, 2022) | ||
14-64468442-G-C | not specified | Uncertain significance (Mar 31, 2023) | ||
14-64468518-A-C | not specified | Uncertain significance (Aug 17, 2022) | ||
14-64468530-G-T | not specified | Uncertain significance (Dec 08, 2023) | ||
14-64468561-C-T | not specified | Uncertain significance (Aug 09, 2021) | ||
14-64468621-G-T | not specified | Uncertain significance (Nov 17, 2022) | ||
14-64468626-G-T | not specified | Uncertain significance (Dec 16, 2023) | ||
14-64468666-G-T | not specified | Uncertain significance (May 03, 2023) | ||
14-64468680-A-C | not specified | Uncertain significance (Feb 06, 2024) | ||
14-64468713-C-T | not specified | Uncertain significance (Jan 26, 2023) | ||
14-64468777-C-T | not specified | Uncertain significance (Nov 22, 2021) | ||
14-64468891-A-C | not specified | Uncertain significance (Jun 29, 2023) | ||
14-64468892-G-C | not specified | Uncertain significance (Oct 12, 2021) | ||
14-64468909-A-G | not specified | Uncertain significance (Jun 10, 2024) | ||
14-64468911-G-C | not specified | Uncertain significance (Dec 01, 2022) | ||
14-64468957-G-A | Benign (Dec 31, 2019) | |||
14-64469022-A-T | not specified | Uncertain significance (Mar 16, 2022) | ||
14-64469043-G-C | not specified | Uncertain significance (May 20, 2024) | ||
14-64469053-A-C | not specified | Uncertain significance (Jun 30, 2023) | ||
14-64469071-G-A | not specified | Uncertain significance (Apr 04, 2024) | ||
14-64469076-C-G | not specified | Uncertain significance (Apr 12, 2024) | ||
14-64469098-C-G | not specified | Uncertain significance (Apr 12, 2024) | ||
14-64469143-T-C | not specified | Uncertain significance (Jun 24, 2022) | ||
14-64469166-C-G | not specified | Uncertain significance (Mar 17, 2023) | ||
14-64469236-G-A | not specified | Uncertain significance (Feb 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AKAP5 | protein_coding | protein_coding | ENST00000394718 | 1 | 9005 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.652 | 0.347 | 125679 | 0 | 2 | 125681 | 0.00000796 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.17 | 164 | 212 | 0.773 | 0.00000992 | 2811 |
Missense in Polyphen | 28 | 42.15 | 0.6643 | 633 | ||
Synonymous | 0.787 | 66 | 74.6 | 0.884 | 0.00000338 | 817 |
Loss of Function | 2.68 | 2 | 12.1 | 0.166 | 5.08e-7 | 188 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May anchor the PKA protein to cytoskeletal and/or organelle-associated proteins, targeting the signal carried by cAMP to specific intracellular effectors. Association with to the beta2-adrenergic receptor (beta2-AR) not only regulates beta2-AR signaling pathway, but also the activation by PKA by switching off the beta2-AR signaling cascade.;
- Pathway
- G Protein Signaling Pathways;Developmental Biology;Metabolism;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Regulation of insulin secretion;Neuronal System;ROBO receptors bind AKAP5;Signaling by ROBO receptors;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Axon guidance;Integration of energy metabolism;Role of Calcineurin-dependent NFAT signaling in lymphocytes;Calcium signaling in the CD4+ TCR pathway
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.73
- rvis_percentile_EVS
- 86.08
Haploinsufficiency Scores
- pHI
- 0.0917
- hipred
- Y
- hipred_score
- 0.643
- ghis
- 0.430
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.312
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Akap5
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- protein targeting;signal transduction;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;negative regulation of adenylate cyclase activity;chemical synaptic transmission;regulation of protein kinase A signaling;positive regulation of adenylate cyclase activity;positive regulation of protein localization to plasma membrane
- Cellular component
- cytosol;plasma membrane;cytoplasmic side of plasma membrane;postsynaptic density;dendrite membrane;dendritic spine;membrane raft;excitatory synapse
- Molecular function
- protein binding;calmodulin binding;adenylate cyclase binding;SH3 domain binding;protein phosphatase 2B binding;beta-2 adrenergic receptor binding;protein-containing complex scaffold activity;protein kinase A regulatory subunit binding;glutamate receptor binding;GABA receptor binding;protein kinase A binding;scaffold protein binding